Ligand validation:6ZAH

ACV: L-D-(A-AMINOADIPOYL)-L-CYSTEINYL-D-VALINE

ACV is a Ligand Of Interest in 6ZAH designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6ZAH_ACV_A_402	91%	87%	0.071	0.957	0.22	0.47	-	-	0	0	100%	1
1BK0_ACV_A_351	99%	38%	0.051	0.982	0.91	1.49	1	7	0	0	100%	1
8BBA_ACV_A_404	99%	76%	0.055	0.986	0.38	0.56	-	-	0	0	100%	1
6ZAE_ACV_A_403	98%	88%	0.053	0.977	0.26	0.41	-	-	0	0	100%	1
7ZOE_ACV_A_403	97%	87%	0.065	0.978	0.25	0.45	-	-	0	0	100%	1
7PSW_ACV_A_402	97%	70%	0.069	0.981	0.45	0.7	-	1	0	0	100%	1
6ZAF_ACV_A_402	96%	84%	0.057	0.968	0.25	0.5	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.